Search alternatives:
host resistance » plant resistance (Expand Search)
increased tumor » increased number (Expand Search), increased time (Expand Search)
decrease host » decreases short (Expand Search)
host resistance » plant resistance (Expand Search)
increased tumor » increased number (Expand Search), increased time (Expand Search)
decrease host » decreases short (Expand Search)
-
81
CDC20 inhibition increases sensitivity to TMZ in adherent and neurospheres GSCs.
Published 2022Subjects: -
82
Image_6_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF
Published 2019“…<p>Reprogrammed glucose metabolism and increased glycolysis have been implicated in tumor chemoresistance. …”
-
83
Table_1_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.DOCX
Published 2019“…<p>Reprogrammed glucose metabolism and increased glycolysis have been implicated in tumor chemoresistance. …”
-
84
Image_2_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF
Published 2019“…<p>Reprogrammed glucose metabolism and increased glycolysis have been implicated in tumor chemoresistance. …”
-
85
Image_1_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF
Published 2019“…<p>Reprogrammed glucose metabolism and increased glycolysis have been implicated in tumor chemoresistance. …”
-
86
Image_5_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF
Published 2019“…<p>Reprogrammed glucose metabolism and increased glycolysis have been implicated in tumor chemoresistance. …”
-
87
Image_4_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF
Published 2019“…<p>Reprogrammed glucose metabolism and increased glycolysis have been implicated in tumor chemoresistance. …”
-
88
Image_3_Glucose Metabolites Exert Opposing Roles in Tumor Chemoresistance.TIF
Published 2019“…<p>Reprogrammed glucose metabolism and increased glycolysis have been implicated in tumor chemoresistance. …”
-
89
-
90
Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
91
Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
92
Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
93
Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
94
Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
95
Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Table from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
96
Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
97
Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis
Published 2023“…Supplementary Figure from GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis…”
-
98
-
99
Figure 7 from MUC1-C Dictates PBRM1-Mediated Chronic Induction of Interferon Signaling, DNA Damage Resistance, and Immunosuppression in Triple-Negative Breast Cancer
Published 2025“…<p>MUC1 and PBRM1 associate with decreases in responsiveness of TNBC tumors to chemotherapy. …”
-
100
CDC20 inhibition increased cell death following treatment with TMZ or radiation.
Published 2022Subjects: